Peritoneal dialysis composition and method usable during and...

A - Human Necessities – 61 – M

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61M 1/28 (2006.01) A61K 47/18 (2006.01) A61K 47/22 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2102234

Peritoneal dialysis solutions are specially formulated for use during and immediately after an episode of peritonitis. The solutions include one or more additives to minimize the injury and physiological effects that peritonitis can cause. One additive is a mixture of amino acids sufficient to maintain a positive nitrogen balance, at least one of the amino acids being present in a dipeptide form. Another additive is a compound that scavenges free radicals generated by peritoneal macrophages activated by the peritonitis. Another additive is chondroitin sulfate that changes the permeability of the peritoneal membrane during subsequent dialysis using solutions free of chondroitin sulfate. Another additive is the degradation products of hyaluronic acid to enhance the regeneration of the pritoneal mesothelium without fibrosis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peritoneal dialysis composition and method usable during and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peritoneal dialysis composition and method usable during and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peritoneal dialysis composition and method usable during and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1948210

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.